Home › Compare › VRAY vs BTI

VRAY vs BTI: Dividend Comparison 2026

VRAY yields 8000.00% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRAY wins by $6139401296821770.00M in total portfolio value
10 years
VRAY
VRAY
● Live price
8000.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6139401296821770.00M
Annual income
$5,992,060,180,362,265,000,000.00
Full VRAY calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — VRAY vs BTI

📍 VRAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRAYBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRAY + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VRAY pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRAY
Annual income on $10K today (after 15% tax)
$680,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,093,251,153,307,925,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, VRAY beats the other by $5,093,251,153,307,925,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRAY + BTI for your $10,000?

VRAY: 50%BTI: 50%
100% BTI50/50100% VRAY
Portfolio after 10yr
$3069700648410885.00M
Annual income
$2,996,030,090,181,132,400,000.00/yr
Blended yield
97.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

VRAY
Analyst Ratings
3
Buy
8
Hold
Consensus: Hold
Price Target
$6.25
+24900.0% upside vs current
Range: $4.00 — $8.00
Altman Z
-6.1
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRAY buys
0
BTI buys
0
No recent congressional trades found for VRAY or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRAYBTI
Forward yield8000.00% ✓5.40%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$6139401296821770.00M ✓$37.8K
Annual income after 10y$5,992,060,180,362,265,000,000.00 ✓$2,802.29
Total dividends collected$6129555735022888.00M ✓$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy
Analyst price target$6.25$40.00 ✓

Year-by-year: VRAY vs BTI ($10,000, DRIP)

YearVRAY PortfolioVRAY Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$810,700$800,000.00$11,301$601.08+$799.4K → VRAY
2$61,480,533$60,613,084.11$12,799$706.58+$61.47M → VRAY
3$4,361,742,463$4,295,958,292.40$14,527$832.38+$4361.73M → VRAY
4$289,505,553,392$284,838,488,956.41$16,527$982.75+$289505.54M → VRAY
5$17,978,762,985,621$17,668,992,043,491.98$18,846$1,162.95+$17978762.97M → VRAY
6$1,044,726,039,031,441$1,025,488,762,636,826.10$21,545$1,379.49+$1044726039.01M → VRAY
7$56,809,462,631,941,760$55,691,605,770,178,120.00$24,694$1,640.41+$56809462631.92M → VRAY
8$2,891,032,380,267,701,000$2,830,246,255,251,523,600.00$28,378$1,955.69+$2891032380267.67M → VRAY
9$137,701,977,999,537,290,000$134,608,573,352,650,870,000.00$32,702$2,337.79+$137701977999537.27M → VRAY
10$6,139,401,296,821,770,000,000$5,992,060,180,362,265,000,000.00$37,794$2,802.29+$6139401296821770.00M → VRAY

VRAY vs BTI: Complete Analysis 2026

VRAY — Stock

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Full VRAY Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this VRAY vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRAY vs SCHDVRAY vs JEPIVRAY vs OVRAY vs KOVRAY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.